Skip to main content
. 2019 Sep;221(3):245.e1–245.e15. doi: 10.1016/j.ajog.2019.04.035

Figure 2.

Figure 2

Molecular landscape of isolated lymph node relapse and extranodal relapse ovarian carcinoma

A, Genomic events in ILNR and ENR cases. B, Tumor-infiltrating lymphocyte burden of ILNR and ENR HGS ovarian carcinomas.

ENR, extranodal relapse; HGS, high-grade serous; ILNR, isolated lymph node relapse; LGS, low-grade serous.

Hollis et al. Clinical and molecular characterization of ILNR ovarian carcinoma. Am J Obstet Gynecol 2019.